Asymmetric dimethylarginine and hypertension in cerebral small vessel disease [1]

Stroke

Volumn 38, Issue 7, 2007, Pages

  Tsuda, Kazushi ^a  

^a KANSAI UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

BLOOD PRESSURE MONITORING; CEREBROVASCULAR DISEASE; CORRELATION ANALYSIS; HUMAN; HYPERTENSION; LETTER; METABOLISM; MICROCIRCULATION; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ARGININE; BLOOD PRESSURE; CEREBROVASCULAR DISORDERS; ENZYME INHIBITORS; HUMANS; HYPERTENSION; LEUKOARAIOSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 34347351319     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.484063     Document Type: Letter

References (5)

1. Khan U, Hassan A, Vallance P, Markus HS. Asymmetric dimethylarginine in cerebral small vessel disease. Stroke. 2007;38:411-413.
2. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol. 2003;23:1455-1459.
3. Kielstein JT, Impraim B, Simmel S, Bode-Boeger SM, Tsikas D, Frolich JC, Hoeper MM, Haller H, Fliser D. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation. 2004;109:172-177.
4. Scuteri A, Stühlinger MC, Cooke JP, Wright JG, Lakatta EG, Anderson DE, Fleg JL. Nitric oxide inhibition as a mechanism for blood pressure increase during salt loading in normotensive postmenopausal women. J Hypertens. 2003;21:41339-41346.
5. Tsuda K, Nishio I. An association between plasma asymmetric dimethylarginine and membrane fluidity of erythrocytes in hypertensive and normotensive men: an electron paramagnetic resonance investigation. Am J Hypertens. 2005;18:1243-1248.